1. 1130. Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure – Results from the placebo-controlled EMPATHY trial. (15th December 2022) Authors: Abrishamian, Luis; Bonten, Marc; Chandra, Richa; Elango, Damodaran Solai; Fustier, Pierre; Gedif, Kinfemichael; Goncalves, Susana; Igbinadolor, Awawu; Kingsley, Jeff; Knutson, Charles G; Kukkaro, Petra; Kumarasamy, Nagalingeswaran; Legenne, Philippe; Mekebeb-Reuter, Martha; Ramanathan, Krishnan; ... Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK. Issue 7 (22nd July 2021) Authors: Ogura, Yuichiro; Jaffe, Glenn J; Cheung, Chui Ming Gemmy; Kokame, Gregg T; Iida, Tomohiro; Takahashi, Kanji; Lee, Won Ki; Chang, Andrew A; Monés, Jordi; D'Souza, Divya; Weissgerber, Georges; Gedif, Kinfemichael; Koh, Adrian Journal: British journal of ophthalmology Issue: Volume 106:Issue 7(2022) Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗